X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE NOVARTIS TTK HEALTHCARE/
NOVARTIS
 
P/E (TTM) x 53.5 363.2 14.7% View Chart
P/BV x 9.8 17.9 55.1% View Chart
Dividend Yield % 0.3 1.6 18.3%  

Financials

 TTK HEALTHCARE   NOVARTIS
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
NOVARTIS
Mar-16
TTK HEALTHCARE/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs663982 67.6%   
Low Rs399556 71.7%   
Sales per share (Unadj.) Rs535.6252.9 211.8%  
Earnings per share (Unadj.) Rs15.962.1 25.7%  
Cash flow per share (Unadj.) Rs20.063.3 31.6%  
Dividends per share (Unadj.) Rs4.0010.00 40.0%  
Dividend yield (eoy) %0.81.3 57.9%  
Book value per share (Unadj.) Rs137.6363.6 37.8%  
Shares outstanding (eoy) m7.7731.96 24.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.0 32.6%   
Avg P/E ratio x33.312.4 269.2%  
P/CF ratio (eoy) x26.512.2 218.3%  
Price / Book Value ratio x3.92.1 182.5%  
Dividend payout %25.116.1 155.9%   
Avg Mkt Cap Rs m4,12724,580 16.8%   
No. of employees `0001.70.8 227.1%   
Total wages/salary Rs m6071,801 33.7%   
Avg. sales/employee Rs Th2,436.710,748.9 22.7%   
Avg. wages/employee Rs Th355.22,395.2 14.8%   
Avg. net profit/employee Rs Th72.52,641.1 2.7%   
INCOME DATA
Net Sales Rs m4,1628,083 51.5%  
Other income Rs m61829 7.4%   
Total revenues Rs m4,2238,913 47.4%   
Gross profit Rs m197234 84.2%  
Depreciation Rs m3237 86.4%   
Interest Rs m302 1,661.1%   
Profit before tax Rs m1971,025 19.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m017 0.0%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m73752 9.7%   
Profit after tax Rs m1241,986 6.2%  
Gross profit margin %4.72.9 163.5%  
Effective tax rate %37.073.4 50.5%   
Net profit margin %3.024.6 12.1%  
BALANCE SHEET DATA
Current assets Rs m1,62912,678 12.8%   
Current liabilities Rs m1,0582,433 43.5%   
Net working cap to sales %13.7126.7 10.8%  
Current ratio x1.55.2 29.5%  
Inventory Days Days3033 91.1%  
Debtors Days Days3422 149.4%  
Net fixed assets Rs m55669 803.9%   
Share capital Rs m78160 48.6%   
"Free" reserves Rs m87811,460 7.7%   
Net worth Rs m1,06911,621 9.2%   
Long term debt Rs m1590-   
Total assets Rs m2,39914,400 16.7%  
Interest coverage x7.6570.5 1.3%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.70.6 309.0%   
Return on assets %6.413.8 46.4%  
Return on equity %11.617.1 67.8%  
Return on capital %18.523.6 78.3%  
Exports to sales %0.80.7 106.1%   
Imports to sales %1.418.6 7.5%   
Exports (fob) Rs m3360 54.7%   
Imports (cif) Rs m581,503 3.9%   
Fx inflow Rs m33186 17.7%   
Fx outflow Rs m631,821 3.5%   
Net fx Rs m-30-1,635 1.9%   
CASH FLOW
From Operations Rs m1272,531 5.0%  
From Investments Rs m-146-8,270 1.8%  
From Financial Activity Rs m22-386 -5.7%  
Net Cashflow Rs m3-6,125 -0.0%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 2.0 185.0%  
FIIs % 5.2 1.6 325.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 21.5 120.0%  
Shareholders   12,723 41,647 30.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DISHMAN PHARMA  ELDER PHARMA  VENUS REMEDIES  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 20, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS